Theratechnologies Stock Quote THTX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.20

Bid

1.20

Ask

1.21

Volume

3,496

1.20 Day's Range 1.23

0.88 52 Week Range 2.58

Market Cap

55.176M

Previous Close

1.17

Open

1.23

Last Trade

1.2

Last Trade Time

11:22:37

Financial Volume

$ 4,270

VWAP

1.2213

Average Volume (3m)

38,258

Shares Outstanding

45,980,019

Dividend Yield

PE Ratio

-2.30

Earnings Per Share (EPS)

-0.52

Revenue

81.76M

Net Profit

-23.96M

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.theratech.com

Headquarters

Quebec City, Quebec, Can

Founded

Theratechnologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker THTX. The last closing price for Theratechnologies was $1.17. Over the last year, Theratechnologies shares have traded in a share price range of $ 0.88 to $ 2.58.

Theratechnologies currently has 45,980,019 shares outstanding. The market capitalization of Theratechnologies is $53.80 million. Theratechnologies has a price to earnings ratio (PE ratio) of -2.30.

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.11	-8.39694656489	1.31	1.31	1.16	67646	1.20266533	CS
4	-0.1	-7.69230769231	1.3	1.42	1.16	29959	1.23097929	CS
12	-0.16	-11.7647058824	1.36	1.74	1.16	38258	1.39978776	CS
26	-0.02	-1.6393442623	1.22	1.74	1.08	30879	1.388075	CS
52	-0.88	-42.3076923077	2.08	2.58	0.88	79573	1.45947048	CS
156	-14.92	-92.5558312655	16.12	16.64	0.88	117519	5.19977833	CS
260	-13.96	-92.0844327177	15.16	17.8396	0.88	153865	8.48668561	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OCTOEightco Holdings Inc	$ 3.92 (57.43%)	85.23M
SBCSBC Medical Group Holdings Incorporated	$ 9.90 (49.32%)	1.17M
RZLVRezolve AI Ltd	$ 6.9311 (40.88%)	876.27k
CAPRCapricor Therapeutics Inc	$ 12.0799 (32.75%)	17M
TNONTenon Medical Inc	$ 5.10 (26.87%)	18.14M
VTNRVertex Energy Inc	$ 0.1339 (-62.91%)	23.8M
CMCTCreative Media and Community Trust Corporation	$ 0.7164 (-54.22%)	1.58M
SFIXStitch Fix Inc	$ 2.405 (-35.87%)	9.24M
BNZIBanzai International Inc	$ 5.6001 (-32.04%)	2.08M
SHOTWSafety Shot Inc	$ 0.23 (-28.13%)	8.77k
NVDANVIDIA Corporation	$ 124.23 (2.78%)	134.6M
CEROCERo Therapeutics Holdings Inc	$ 0.1011 (7.90%)	100.16M
OCTOEightco Holdings Inc	$ 3.92 (57.43%)	85.23M
MLGOMicroAlgo Inc	$ 0.2685 (24.19%)	82.78M
SQQQProShares UltraPro Short QQQ	$ 7.46 (-2.48%)	58.86M